Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Laura Palagini, MD, PhD
JCP
Brief Report
Dual Orexin Receptor Antagonists and Suicide Risk
September 27, 2023
According to the WHO pharmacovigilance database, suicidal behavior was 1.3 times more frequent than expected with dual orexin receptor antagonists and 4.7 times more frequent for Z-drugs; data on...
Francesco Salvo
,
Laura Palagini
,
Pierre A. Geoffroy
JCP
Letter to the Editor
Aggravation of Suicide Risk With Daridorexant: Currently Not Enough Data to Show a Link
July 3, 2023
Palagini and colleagues comment on a recent letter that suggested a role for daridorexant, a new hypnotic, in increasing suicide risk.
Laura Palagini
,
Pierre A. Geoffroy
,
Jean Arthur Micoulaud-Franchi
, et al
JCP
Original Research
Chronobiological Rhythms, Hopelessness, and Suicide Risk
January 19, 2021
Evidence has shown that bipolar disorder is often linked to alterations in circadian rhythms. This study looked at the impact of these rhythms on suicide risk, as well as...
Laura Palagini
,
Mario Miniati
,
Danila Caruso
, et al
